慢性阻塞性肺疾病表型与急性加重相关性的研究进展被引量：6

Development of the relationship between COPD phenotype and AECOPD

导出

摘要 COPD是一种异质性明显的疾病。目前COPD大体分为8个表型：临床表型、生理表型、影像学表型、COPD频发急性加重表型、全身炎症表型、合并症表型、多维指数测评表型和ACOS表型。COPD急性加重（AECOPD）是影响疾病发病率、病死率、生活质量、医疗费用的最主要因素。本文就COPD各种表型与AECOPD之间相关性的研究进展进行总结。 Chronic obstructive pulmonary disease（COPD）is a heterogeneous disease obviously. Recently, COPD phenotypes may generally divide into eight subtypes： clinical phenotype, physiological phenotype, radiologic phenotype, acute exacerbations of COPD phenotype, systemic inflammatory phenotype, complication phenotype, multidimensional index evaluation phenotype, ACOS phenotype. AECOPD are the cardinal factor associated with mortality, morbidity, impaired quality of life and healthcare costs in the disease. This review focuses on discussing the association between different COPD phenotypes and AECOPD.

作者何斌周敏

机构地区上海交通大学附属瑞金医院呼吸内科上海市闵行区中心医院呼吸内科

出处《国际呼吸杂志》 2016年第19期1498-1503,共6页 International Journal of Respiration

关键词慢性阻塞性肺疾病表型急性加重 Chronic obstructive pulmonary disease Phenotype Acute exacerbation

分类号 R563.9 [医药卫生—呼吸系统]

引文网络
相关文献

参考文献46

1Global Initiative for Chronic Obstructive Lung Disease (GOLD). Global strategy for the diagnosis, management and prevention of COPD. GOLD[EB/OL]. Am J Respir Crit Care Med, 2013.
2Available at : www. goldcopd, org. Lozano R, Naghavi M, Foreman K, et al. Global and regional mortality from 235 causes of death for 20 age groups in 1990 and 2010: a systematic analysis for the Global Burden of Disease Study 2010[J]. Lancet, 2012, 380(9859) :2095 2128. DOI:10. 1016/S0140-6736(12)61728-0.
3Anzueto A. Impact of exacerbations on COPD[J]. Eur Respir Rev, 2010, 19 (116): 113-118. DOI: 10. 1183/09059180. 00002610.
4Han MK, Agusti A, Calverley PM, et al. Chronic obstructive pulmonary disease phenotypes:the future of COPD[J]. Am J Respir Crit Care Med,2010,182(5) :598 604. DOI: 10. 1164/ rccm. 200912-1843CC.
5Magnoni MS, Rizzi A, Visconti A, et al. AIMAR survey on COPD phenotypes [J]. Multidiscip Respir Med, 2014, 9 ( 1 ) : 16. DOI: 10. 1186/2049-6958-9-16.
6Sullivan SD, Ramsey SD, Lee TA. The economic burden of COPD[J]. Chest, 2000, 117(2 Suppl) : 5S-9S. DOI: 10. 1378/ chest. 117.2_suppl. 5S.
7Beeh KM, Glaab T, Stowasser S, et al. Characterisation of exacerbation risk and exacerbator phenotypes in the POET- COPDtrial[J]. Respir Res, 2013, 14: 116. DOI: 10. 1186/ 1465-9921-14-116.
8Garcia-Sidro P, Naval E, Martinez Rivera C, et al. The CAT (COPD assessment test) questionnaire as a predictor of the evolution of severe COPD exacerbations [J]. Respir Med, 2015,109(12):1546-1552. DOI:10. 1016/j. rmed. 2015. 10. 011.
9Wise RA. The value of forced expiratory volume in 1 second decline in the assessment of chronic obstructive pulmonary disease progression[J]. Am J Med, 2006,119(10 Suppl 1) :4- 11. DOI : 10. 1016/j. amjmed. 2006.08. 002.
10Donaldson GC, Seemungal TA, Bhowmik A, et al. Relationship between exacerbation frequency and lung function decline in chronic obstructive pulmonary disease[J]. Thorax, 2002, 57 (10): 847-852. DOI: 10. 1136/thorax. 57. 10.847.